Monopar Therapeutics Insider Trading Activity
Monopar Therapeutics Chief Executive Officer Chandler Robinson reported routine equity compensation activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Monopar Therapeutics Chief Executive Officer Chandler Robinson reported routine equity compensation activity. On March 31, 2026, 6,732 restricted stock units vested and were settled into an equal number of common shares at an exercise price of $0.00 per share.
Of these shares, 1,972 were withheld by the issuer at $54.79 per share to cover applicable tax withholding obligations. Following these transactions, Robinson held 90,478 shares of common stock directly and 62,815 shares indirectly through the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit | 6,732 | $0.00 | $0.00 |
| Exercise | Common Stock | 6,732 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,972 | $54.79 | $108K |
| Holding | Common Stock | -- | -- | -- |
Footnotes (5)
- F1. Represents shares acquired on vesting and settlement of restricted stock units.
- F2. Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.
- F3. Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.
- F4. On February 1, 2023, the reporting person was granted 33,803 restricted stock units, vesting 6/48ths (4,225 shares) on June 30, 2023, and 3/48ths (2,113 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
- F5. On March 4, 2025, the reporting person was granted 79,899 restricted stock units of which 6,002 shares vested immediately as of the grant date. The remaining 73,897 restricted stock units vest 6/48ths (9,237 shares) on June 30, 2025, and 3/48ths (4,619 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2028. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.
Key Figures
Key Terms
restricted stock units financial
withholding tax financial
irrevocable trust financial
vesting financial
contingent right financial
AI-generated analysis. How Rhea-AI works. Not financial advice.